Tom Schrader
Analyst
UBS/BTIG
Equibles does not estimate personal net worth.
About Tom Schrader
Tom Schrader is recorded as Analyst at UBS/BTIG. Tom Schrader has spoken on 2 investor events across 1 company, most recently for Acumen Pharmaceuticals, Inc. on September 16, 2026. The companies whose calls Tom Schrader spoke on are classified in the Healthcare sector.
Tom Schrader on recent calls
“Thank you for taking the questions. terrific event uh very related questions but eric is the best we're all going to be looking for comparative signals it's the most likely best comparator cdr sum of boxes versus clarity and then on the oligomer line of questioning you know because you're maybe hitting the toxic…”
“Thank you for taking the questions. terrific event uh very related questions but eric is the best we're all going to be looking for comparative signals it's the most likely best comparator cdr sum of boxes versus clarity and then on the oligomer line of questioning you know because you're maybe hitting the toxic…”
Affiliation history
-
UBS/BTIG
Analyst
Transcript header (unverified)
Current